Balazy M et al. |
Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. |
1988 |
Prostaglandins |
pmid:3070630
|
Falardeau P et al. |
Urinary levels of 2,3-dinor-6-oxo-PGF1 alpha: a reliable index of the production of PGI2 in the spontaneously hypertensive rat. |
1985 |
Prostaglandins |
pmid:3890022
|
Sun FF et al. |
Preparation of two dinor-PGI2 metabolites from 6-keto-PGF1 alpha by Mycobacterium rhodochrous. |
1980 |
Prostaglandins |
pmid:6258195
|
Vesterqvist O and Gréen K |
Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs. |
1984 |
Prostaglandins |
pmid:6548317
|
Stichtenoth DO et al. |
Increased total body synthesis of prostacyclin in rats with adjuvant arthritis. |
1995 Nov-Dec |
Prostaglandins |
pmid:8838242
|
Schaefer WR et al. |
Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. |
1996 |
Prostaglandins |
pmid:8875634
|
Ylikorkala O et al. |
Urinary excretion of prostacyclin and thromboxane metabolites in climacteric women: effect of estrogen-progestin replacement therapy. |
1990 |
Prostaglandins |
pmid:2106714
|
Henriksson P et al. |
Thromboxane synthase inhibition: "endoperoxide shunt phenomenon" does not occur in healthy humans in vivo. |
1990 |
Prostaglandins |
pmid:2106716
|
Grèen K et al. |
Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). |
1989 |
Prostaglandins |
pmid:2664901
|
Huang YS et al. |
Effect of indomethacin treatment on prostaglandin excretion and tissue phospholipid fatty acid composition in rats bearing mammotropic pituitary tumor, MtT-F4. |
1986 |
Prostaglandins Leukot Med |
pmid:3532134
|